Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 49
Filter
1.
PLoS One ; 16(6): e0251991, 2021.
Article in English | MEDLINE | ID: mdl-34106946

ABSTRACT

Based on the investigation of financial fairness perception and donation intention of individual donors in non-profit organizations (NPOs), this paper uses structural equation model to analyze the impact of individual donors' financial fairness perception on donation intention. The results show that individual donors' perceptions on financial result fairness, financial procedure fairness and financial information fairness all have positive impact on donation intention; among which the perception on financial result fairness only has direct impact on individual donation intention, while the perceptions on financial procedure fairness and financial information fairness have direct and indirect impact on individual donation intention.


Subject(s)
COVID-19/economics , Gift Giving/ethics , Motivation/ethics , Organizations, Nonprofit/economics , Pandemics/economics , Perception/ethics , SARS-CoV-2/isolation & purification , Adult , COVID-19/prevention & control , COVID-19/psychology , COVID-19/virology , Female , Humans , Intention , Male , Middle Aged , Organizations, Nonprofit/ethics , Organizations, Nonprofit/statistics & numerical data , Pandemics/ethics , Surveys and Questionnaires , Young Adult
2.
J Health Polit Policy Law ; 46(2): 235-276, 2021 04 01.
Article in English | MEDLINE | ID: mdl-32955566

ABSTRACT

CONTEXT: Industry influence on health science and policy is a critical issue of our day. In 2015 the New York Times revealed that Coca-Cola paid scientists to form a Global Energy Balance Network promoting the notion that exercise, not dietary restraint, is the solution to the obesity epidemic-a claim few accept. This article examines the organizational dynamics and policy process behind Coke's efforts to sway obesity policy-globally and in China, a critical market-during 1995-2015. METHODS: In-depth, qualitative research during 2013-18 involved 10 weeks of fieldwork in Beijing, interviews with 25 leading experts, analysis of newsletters documenting all major obesity-related activities in China, interviews with 10 Euro-American experts, and extensive internet research on all major actors. FINDINGS: This article tells two intertwined stories (institutional dynamics, science making and policy making) at global and local-Chinese levels. Coke succeeded in redirecting China's obesity science and policy to emphasize physical activity. Key to its success was the industry-funded global nonprofit International Life Sciences Institute (ILSI). Beneath ILSI's public narrative of unbiased science and no policy advocacy lay a maze of hidden channels companies used to advance their interests. Working through those channels, Coca-Cola influenced China's science making and policy making during every phase in the policy process, from framing the issues to drafting official policy. CONCLUSIONS: Though China is exceptional, ILSI promoted exercise globally, suggesting potentially significant impacts in other ILSI-branch countries.


Subject(s)
Carbonated Beverages , Exercise , Food Industry/ethics , Health Policy , Obesity/prevention & control , Policy Making , China , Deception , Humans , Organizations, Nonprofit/ethics , Qualitative Research , Societies, Scientific/ethics
3.
Cornea ; 39(10): 1207-1214, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32118673

ABSTRACT

PURPOSE: To describe the ethical attitudes of corneal surgeons and eye bank leadership toward for-profit entities in corneal donation, processing, and distribution. METHODS: Fifty postfellowship corneal surgeons practicing in the United States and 25 eye bank leaders (eg, eye bank directors, CEOs, or presidents) for the Eye Bank Association of America-accredited eye banks completed a 22-question interview, focusing on corneal donation industry changes, including the entry of for-profit institutions. RESULTS: Most participants in both study groups agreed that they have concerns with the entry of for-profit businesses into eye banking (62% corneal surgeons, 68% eye bank leadership), although physicians partnered with a for-profit corneal processor were significantly more likely to have no concerns with the entry of for-profits into eye banking than corneal surgeons partnered with a nonprofit processor (P = 0.04). The most frequently identified concerns with the entry of for-profit businesses into corneal banking were the hypothetical loss of donor trust (56% corneal surgeons, 64% eye bank leadership, P = 0.04) and the potential exploitation of donor generosity (72% corneal surgeons, 60% eye bank leadership). Qualitative theme analysis suggests that both study groups may view increased research/innovation as a potential benefit (64% corneal surgeons, 66% eye bank leadership) of for-profits in eye banking. CONCLUSIONS: Key stakeholders in eye banking do hold relevant ethical beliefs toward recent industry changes, and these attitudes should be considered in the future creation of the ethical corneal donation policy. Further research is needed to assess the attitudes of potential donors and donor families.


Subject(s)
Attitude of Health Personnel , Cornea , Eye Banks/ethics , Health Facilities, Proprietary/ethics , Ophthalmologists/ethics , Corneal Diseases/surgery , Corneal Transplantation/ethics , Ethics, Institutional , Eye Banks/standards , Female , Health Surveys , Humans , Leadership , Male , Ophthalmologists/standards , Organizations, Nonprofit/ethics , Surveys and Questionnaires , Tissue Donors/ethics , Tissue and Organ Procurement/ethics , United States
4.
Trends Mol Med ; 24(5): 429-432, 2018 05.
Article in English | MEDLINE | ID: mdl-29588144

ABSTRACT

The optimism surrounding multistakeholder research initiatives does not match the clear view of policies that are needed to exploit the potential of these collaborations. Here we propose some action items that stem from the integration between research advancements with the perspectives of patient-advocacy organizations, academia, and industry.


Subject(s)
Biomedical Research/methods , Cooperative Behavior , Academies and Institutes , Biomedical Research/organization & administration , Biomedical Research/trends , Humans , Industry , Organizations, Nonprofit/ethics , Patient Advocacy/ethics
5.
Pharm Res ; 35(3): 52, 2018 Feb 07.
Article in English | MEDLINE | ID: mdl-29417233

ABSTRACT

In wealthy nations, non-profit drug R&D has been proposed to reduce the prices of medicines. We sought to review the ethical and economic issues concerning non-profit drug R&D companies, and the possible impact that their pricing strategy may have on the innovation efforts from for-profit companies targeting the same segment of the pharmaceutical market. There are two possible approaches to pricing drugs developed by non-profit R&D programs: pricing that maximises profits and "affordable" pricing that reflects the cost of manufacturing and distribution, plus a margin that ensures sustainability of the drug supply. Overall, the non-profits face ethical challenges - due to the lack of resources, they are unable to independently commercialize their products on a large scale; however, the antitrust law does not permit them to impose prices on potential licensees. Also, reduced prices for the innovative products may result in drying the for-profit R&D in the area.


Subject(s)
Commerce/ethics , Drug Development/ethics , Organizations, Nonprofit/ethics , Pharmaceutical Research/ethics , Commerce/economics , Drug Development/economics , Drug Development/methods , Models, Economic , Organizations, Nonprofit/economics , Pharmaceutical Research/economics , Pharmaceutical Research/methods
6.
Womens Health Issues ; 28(1): 14-20, 2018.
Article in English | MEDLINE | ID: mdl-29158038

ABSTRACT

BACKGROUND: Pregnancy resource centers (PRCs) are nonprofit organizations with a primary mission of promoting childbirth among pregnant women. Given a new state grant program to publicly fund PRCs, we analyzed Georgia PRC websites to describe advertised services and related health information. METHODS: We systematically identified all accessible Georgia PRC websites available from April to June 2016. Entire websites were obtained and coded using defined protocols. RESULTS: Of 64 reviewed websites, pregnancy tests and testing (98%) and options counseling (84%) were most frequently advertised. However, 58% of sites did not provide notice that PRCs do not provide or refer for abortion, and 53% included false or misleading statements regarding the need to make a decision about abortion or links between abortion and mental health problems or breast cancer. Advertised contraceptive services were limited to counseling about natural family planning (3%) and emergency contraception (14%). Most sites (89%) did not provide notice that PRCs do not provide or refer for contraceptives. Two sites (3%) advertised unproven "abortion reversal" services. Approximately 63% advertised ultrasound examinations, 22% sexually transmitted infection testing, and 5% sexually transmitted infection treatment. None promoted consistent and correct condom use; 78% with content about condoms included statements that seemed to be designed to undermine confidence in condom effectiveness. Approximately 84% advertised educational programs, and 61% material resources. CONCLUSIONS: Georgia PRC websites contain high levels of false and misleading health information; the advertised services do not seem to align with prevailing medical guidelines. Public funding for PRCs, an increasing national trend, should be rigorously examined. Increased regulation may be warranted to ensure quality health information and services.


Subject(s)
Advertising , Deception , Family Planning Services , Internet , Organizations, Nonprofit , Reproductive Health Services , Abortion, Induced , Access to Information , Condoms , Contraception/methods , Contraceptive Agents , Counseling , Family Planning Services/ethics , Family Planning Services/standards , Female , Financing, Government , Georgia , Health Education , Health Resources , Humans , Organizations, Nonprofit/ethics , Organizations, Nonprofit/standards , Pregnancy , Reproductive Health Services/ethics , Reproductive Health Services/standards , Sexual Behavior , Sexually Transmitted Diseases/diagnosis , Sexually Transmitted Diseases/therapy , Ultrasonography, Prenatal
8.
Rev. bioét. derecho ; (40): 49-61, jul. 2017.
Article in Spanish | IBECS | ID: ibc-163456

ABSTRACT

El estatuto jurídico de las partes separadas del cuerpo humano (sean órganos, tejidos, células o fluidos) está sometido a discusión, debido a dos motivos: la falta de claridad de dicho estatuto y la urgencia de disponer de él. El «enfoque propietarista» se define por proponer el estatuto genérico de objetos de propiedad privada para las partes separadas del cuerpo. Es indudable que este enfoque presenta muchas ventajas; sin embargo, es posible que tales ventajas no sean suficientes para justificarlo. Con la intención de evaluar esta propuesta, se identifican aquí los fines que debe satisfacer el estatuto jurídico elegido, a partir de los cuales cabe articular un test de aptitud o pertinencia. La aplicación del test a la propiedad privada parece dar un resultado negativo


The legal status of detached human body parts (either organs, tissue, cells or fluids) is under discussion, due to the lack of clarity of such a status and to the pressing need of it. The «property approach» suggests the general status of objects of private property as the most suitable for the detached parts of human bodies. Undoubtedly, the property approach shows many advantages; but they may not be enough to justify it. Looking for a fair assessment of this proposal, we begin by identifying the goals that should by satisfied by the legal status of human detached parts; then we build an expediency test with these goals; lastly, we apply our test to private property. The test result seems to be negative


Subject(s)
Humans , Biocompatible Materials/administration & dosage , Constitution and Bylaws , Biotechnology/ethics , Organizations, Nonprofit/ethics , Organizations, Nonprofit/legislation & jurisprudence , Ownership/ethics , Ownership/legislation & jurisprudence
10.
PLoS One ; 12(3): e0174162, 2017.
Article in English | MEDLINE | ID: mdl-28319151

ABSTRACT

BACKGROUND: Natural disasters, armed conflict, migration, and epidemics today occur more frequently, causing more death, displacement of people and economic loss. Their burden on health systems and healthcare workers (HCWs) is getting heavier accordingly. The ethical problems that arise in disaster settings may be different than the ones in daily practice, and can cause preventable harm or the violation of basic human rights. Understanding the types and the determinants of ethical challenges is crucial in order to find the most benevolent action while respecting the dignity of those affected people. Considering the limited scope of studies on ethical challenges within disaster settings, we set upon conducting a qualitative study among local HCWs. METHODS: Our study was conducted in six cities of Turkey, a country where disasters are frequent, including armed conflict, terrorist attacks and a massive influx of refugees. In-depth interviews were carried out with a total of 31 HCWs working with various backgrounds and experience. Data analysis was done concurrently with ongoing interviews. RESULTS: Several fundamental elements currently hinder ethics in relief work. Attitudes of public authorities, politicians and relief organizations, the mismanagement of impromptu humanitarian action and relief and the media's mindset create ethical problems on the macro-level such as discrimination, unjust resource allocation and violation of personal rights, and can also directly cause or facilitate the emergence of problems on the micro-level. An important component which prevents humanitarian action towards victims is insufficient competence. The duty to care during epidemics and armed conflicts becomes controversial. Many participants defend a paternalistic approach related to autonomy. Confidentiality and privacy are either neglected or cannot be secured. CONCLUSION: Intervention in factors on the macro-level could have a significant effect in problem prevention. Improving guidelines and professional codes as well as educating HCWs are also areas for improvement. Also, ethical questions exposed within this study should be deliberated and actualized with universal consensus in order to guide HCWs and increase humane attitudes.


Subject(s)
Health Personnel/ethics , Relief Work/ethics , Altruism , Attitude , Codes of Ethics , Communications Media/ethics , Confidentiality , Health Personnel/psychology , Humans , Interviews as Topic , Models, Theoretical , Moral Obligations , Organizations, Nonprofit/ethics , Personal Autonomy , Politics , Practice Guidelines as Topic , Professional-Patient Relations/ethics , Qualitative Research , Triage/ethics , Turkey
11.
Am J Prev Med ; 52(1): 20-30, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27745783

ABSTRACT

INTRODUCTION: Obesity is a pervasive public health problem in the U.S. Reducing soda consumption is important for stemming the obesity epidemic. However, several articles and one book suggest that soda companies are using their resources to impede public health interventions that might reduce soda consumption. Although corporate sponsorship by tobacco and alcohol companies has been studied extensively, there has been no systematic attempt to catalog sponsorship activities of soda companies. This study investigates the nature, extent, and implications of soda company sponsorship of U.S. health and medical organizations, as well as corporate lobbying expenditures on soda- or nutrition-related public health legislation from 2011 to 2015. METHODS: Records of corporate philanthropy and lobbying expenditures on public health legislation by soda companies in the U.S. during 2011-2015 were found through Internet and database searches. RESULTS: From 2011 to 2015, the Coca-Cola Company and PepsiCo were found to sponsor a total of 95 national health organizations, including many medical and public health institutions whose specific missions include fighting the obesity epidemic. During the study period, these two soda companies lobbied against 29 public health bills intended to reduce soda consumption or improve nutrition. CONCLUSIONS: There is surprisingly pervasive sponsorship of national health and medical organizations by the nation's two largest soda companies. These companies lobbied against public health intervention in 97% of cases, calling into question a sincere commitment to improving the public's health. By accepting funding from these companies, health organizations are inadvertently participating in their marketing plans.


Subject(s)
Carbonated Beverages , Food Industry/economics , Lobbying , Organizations, Nonprofit/ethics , Societies, Medical/ethics , Organizations, Nonprofit/economics , Societies, Medical/economics , United States
12.
Stem Cell Rev Rep ; 12(1): 8-14, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26432702

ABSTRACT

Nonprofit organizations and philanthropists stepped into a funding void caused by controversies over public funding of human embryonic stem cell (hESC) research. Based on interviews of 83 representatives of 53 funders, we examine the motivations and accountability structures of public agencies, corporations, fundraising dependent nonprofit organizations and philanthropic organizations that funded hESC research in three jurisdictions: California, Sweden, and South Korea. While non-traditional forms of funding are essential in the early stages of research advancement, they are unreliable for the long timeframes necessary to advance cell therapies. Such funding sources may enter the field based on high expectations, but may exit just as rapidly based on disappointing rates of progress.


Subject(s)
Cell Transplantation/economics , Fund Raising/statistics & numerical data , Human Embryonic Stem Cells/cytology , Organizations, Nonprofit/economics , Stem Cell Research/economics , California , Cell Differentiation , Cell Transplantation/ethics , Cell Transplantation/statistics & numerical data , Clinical Trials as Topic , Fund Raising/ethics , Human Embryonic Stem Cells/physiology , Humans , Organizations, Nonprofit/ethics , Organizations, Nonprofit/statistics & numerical data , Republic of Korea , Stem Cell Research/ethics , Sweden
13.
Int J Rheum Dis ; 18(6): 606-15, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26012523

ABSTRACT

AIMS: To evaluate the association of financial conflicts of interest (FCOI) with the characteristics, outcome and reported methodological quality of fibromyalgia drug therapy randomized controlled trials (FM-RCTs). METHODS: A cross-sectional study of original, parallel-group, drug therapy FM-RCTs published between 1997 and 2011 from Medline and Cochrane Central Register of Controlled Trials was conducted. Two reviewers independently assessed each RCT for funding source, authors' FCOI(s), study characteristics, reporting of methodological measures important for internal validity and outcome (positive [statistically significant result favoring experimental drug for the primary outcome] or non-positive). RESULTS: Forty-seven RCTs were eligible with funding source as: 26 (55.3%) industry; eight (17%) non-profit source(s); five (10.6%) mixed; and eight (17%) unspecified. Industry-funded RCTs were more likely to be multicenter and enroll greater number of patients. Reporting of key methodological measures was suboptimal; however, industry and non-profit funded RCTs did not differ in their reporting. Thirty (63.8%) RCTs had ≥ one author who disclosed an FCOI (receipt of research grant [21, 44.7%], industry sponsor employee [20, 42.6%], receipt of consultancy fee/honorarium [16, 34%] and stock ownership [11, 23.4%]). Although industry funding and certain authors' FCOIs (employment and receipt of consultancy fee/honorarium) were univariately associated with positive outcome, such association was not observed after adjusting for study sample size. CONCLUSIONS: The majority of FM-RCTs were industry-sponsored, and had at least one author with an FCOI. Reporting of key methodological measures was suboptimal. After adjusting for study sample size, no association of industry funding or author's FCOI with study outcome was seen.


Subject(s)
Analgesics/economics , Analgesics/therapeutic use , Conflict of Interest/economics , Drug Costs , Drug Industry/economics , Fibromyalgia/drug therapy , Fibromyalgia/economics , Organizations, Nonprofit/economics , Randomized Controlled Trials as Topic/economics , Research Support as Topic/economics , Drug Industry/ethics , Fibromyalgia/diagnosis , Humans , Organizations, Nonprofit/ethics , Randomized Controlled Trials as Topic/ethics , Research Support as Topic/ethics , Treatment Outcome
14.
Anthropol Med ; 21(1): 71-86, 2014.
Article in English | MEDLINE | ID: mdl-24552455

ABSTRACT

Based on the case study of an Aids clinic operated in Nanning by MSF, this paper looks at how one international NGO, Médecins Sans Frontières (MSF, or Doctors Without Borders), deals with the HIV-carrier patients in Nanning, the capital of Guangxi province in China. It explores the process of care-giving to the HIV patients by MSF employees (both foreign and local) and how the patients react to the 'care-receiving' provided by this foreign NGO. This is especially pertinent in China today as HIV-patients are the victims of discriminating policies and are still very much discriminated by the general population. MSF, viewed by the victims as a foreign NGO, is regarded as an organization seen as promoting a changing and compassionate attitude toward AIDs patients through their anonymous and non-discriminating practices. Through the practices and the discourse of MSF workers and the testimonies of the patients, this paper looks at how the moral economy of AIDs is evolving from a repressive and discriminative attitude towards the compassionate attention to individual suffering. As such, MSF, through its actions, is seen as one of the agents promoting attitudinal changes toward disadvantaged groups and is facilitating the emergence of an emotional and compassionate subject.


Subject(s)
Acquired Immunodeficiency Syndrome , Delivery of Health Care , Empathy , Organizations, Nonprofit , Acquired Immunodeficiency Syndrome/psychology , Acquired Immunodeficiency Syndrome/therapy , Adult , Anthropology, Medical , China , Delivery of Health Care/ethics , Delivery of Health Care/methods , Delivery of Health Care/organization & administration , Female , Humans , Male , Middle Aged , Morals , Organizations, Nonprofit/ethics , Organizations, Nonprofit/organization & administration , Social Stigma
15.
Health Aff (Millwood) ; 33(1): 39-45, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24395933

ABSTRACT

Communicating openly and honestly with patients and families about unexpected medical events-a policy known as full disclosure-improves outcomes for patients and providers. Although many certification and licensing organizations have declared full disclosure to be imperative, the adoption of and adherence to a full disclosure protocol is not common practice in most clinical settings. We conducted a case study of Ascension Health's implementation of a full disclosure protocol at five labor and delivery demonstration sites. Twenty-seven months after implementation, the rate of full disclosure had increased by 221 percent. Practitioners saw insurers' acceptance of the full disclosure protocol, consistent and ongoing leadership by local practitioners and hospitals, the establishment of a well-trained local investigation and disclosure team, and disclosure training for practitioners as key catalysts for change. Lessons learned from this multisite initiative can inform liability insurers and guide providers who are committed to ensuring that full disclosure becomes the only response to unexpected medical events.


Subject(s)
Catholicism , Communication , Delivery, Obstetric/ethics , Delivery, Obstetric/legislation & jurisprudence , Disclosure/ethics , Disclosure/legislation & jurisprudence , Hospitals, Religious/ethics , Hospitals, Religious/legislation & jurisprudence , Medical Errors/ethics , Medical Errors/legislation & jurisprudence , Obstetric Labor Complications/diagnosis , Organizations, Nonprofit/ethics , Organizations, Nonprofit/legislation & jurisprudence , Ethics, Medical , Female , Health Care Reform/ethics , Health Care Reform/legislation & jurisprudence , Health Plan Implementation/ethics , Health Plan Implementation/legislation & jurisprudence , Humans , Infant, Newborn , Insurance Claim Reporting/ethics , Insurance Claim Reporting/legislation & jurisprudence , Physician-Patient Relations/ethics , Pregnancy , Quality Assurance, Health Care/ethics , Quality Assurance, Health Care/legislation & jurisprudence , United States
16.
J Law Med Ethics ; 41(3): 680-7, 2013.
Article in English | MEDLINE | ID: mdl-24088159

ABSTRACT

Patient advocacy organizations (PAOs) advocate for increased research funding and policy changes and provide services to patients and their families. Given their credibility and political clout, PAOs are often successful in changing policies, increasing research funding, and increasing public awareness of medical conditions and the problems of their constituents. In order to advance their missions, PAOs accept funding, frequently from pharmaceutical firms. Industry funding can help PAOs advance their goals but can also create conflicts of interest (COI). Research indicates that bias may occur, even among well-meaning professionals, when people and organizations have financial COI. Industry funding may therefore influence PAOs to act in ways that favor the interests of their donors, which may increase the risk of harm to patients. This article extends the analysis developed in the Institute of Medicine report, Conflicts of Interest in Medical Research, Education, and Practice, and applies the analysis to understand PAOs and their relationships with industry. It argues that the preferred goal of institutional COI policies should not be to promote trust, but to promote trustworthiness and appropriately placed trust.


Subject(s)
Conflict of Interest , Drug Industry , Lobbying , Organizations, Nonprofit , Patient Advocacy , Humans , Organizations, Nonprofit/ethics , Research Support as Topic/ethics , Trust , United States
19.
JONAS Healthc Law Ethics Regul ; 13(4): 125-31; quiz 132-3, 2011.
Article in English | MEDLINE | ID: mdl-22124472

ABSTRACT

This study investigates ethical climates in government, nonprofit, and for-profit nursing homes and determines their similarities and differences. Surveys were collected from 656 (21.4%) licensed nurses who worked in 100 skilled nursing facilities in one Midwestern state. Shared law and code and caring ethical climates were identified across the 3 sector nursing homes. Those climates were also polarized. Important implications were drawn for consideration of ethical perceptions of each sector during negotiations and contract management.


Subject(s)
Ethics, Institutional , Ownership/ethics , Skilled Nursing Facilities/ethics , Adult , Female , Government , Humans , Middle Aged , Nurses/psychology , Organizational Culture , Organizations, Nonprofit/ethics , Organizations, Nonprofit/organization & administration , Skilled Nursing Facilities/organization & administration , Surveys and Questionnaires
20.
Aten. prim. (Barc., Ed. impr.) ; 43(9): 497-502, sept. 2011.
Article in Spanish | IBECS | ID: ibc-90196

ABSTRACT

Aunque más optimista, el nuevo informe de la Organización Mundial de la Salud (OMS) continúa arrojando datos escalofriantes sobre las desigualdades no sólo en la esperanza de vida sino en múltiples ámbitos. Muchas organizaciones no gubernamentales (ONG) relacionadas con la medicina tratan de paliar este desequilibrio. Sin embargo en la opinión pública y entre los actores surgen dudas sobre la idoneidad y la utilidad a largo plazo de la cooperación.Cooperar no significa acudir de cualquier forma a la llamada del sentimentalismo. La cooperación mueve dinero y se han de rendir cuentas. Exige una fuerte formación tanto en valores profesionales como humanos. Obliga a investigar en vacunas o enfermedades extrañas a nuestra sociedad. Cooperar significa «operar con» la contraparte local, según sus necesidades y su proyecto sanitario global. Y finalmente la Cooperación implica la reivindicación de cambio en ciertos aspectos del orden económico mundial.Reflexionamos sobre estos interrogantes y exponemos los diferentes marcos éticos en que se mueven la mayoría de las ONG(AU)


Although more optimistic, the new report by the World Health Organization (WHO) continues to cast horrifying statistics on inequalities, not only in life expectancy but in many areas. Many Non-Governmental Organisations (NGOs) related to medicine seek to address this imbalance.To cooperate does not in any way appeal to the call of sentimentality. Cooperation moves money and is accountable. It requires a strong background in both professional and human values. It requires research on vaccines and diseases foreign to our society. To cooperate means “operate with” local counterparts, according to their needs and global health project. And finally, cooperation implies the demand for change in certain aspects of the global economic order.We reflect on these questions and describe the different ethical frameworks for the population and NGOs(AU)


Subject(s)
Humans , Male , Female , International Cooperation/history , Organizations, Nonprofit/ethics , Foundations/ethics , Foundations , International Cooperation/legislation & jurisprudence , Organizations, Nonprofit/economics , Organizations, Nonprofit/organization & administration , Organizations, Nonprofit/statistics & numerical data , Organizations, Nonprofit/standards , Foundations/organization & administration , Foundations/statistics & numerical data , Foundations/standards
SELECTION OF CITATIONS
SEARCH DETAIL
...